Evidence map›Paper›PMID 31046425›Full record

ArticleCell transplantation2019

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure.

Gregor Poglajen, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, Bojan Vrtovec

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. CD34 positive cells as endothelial progenitor cells in biology and medicine.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gregor Poglajen1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Gregor Zemljič1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Andraž Cerar1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Sabina Frljak1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Martina Jaklič1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Vesna Androcec1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Bojan Vrtovec1 Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Slovenia.
Ljubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34

Indexed as

AdultAntigens, CD34Arrhythmias, CardiacCell- and Tissue-Based TherapyChronic DiseaseEchocardiographyFemaleHeart FailureHumansMaleMiddle AgedAntigens, CD34heart failurestem cell therapyventricular arrhythmias

Identifiers

PMID31046425
PMCPMC6719496
OpenAlexW2943692380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.